THE PLACE OF SURGERY IN MODERN TREATMENT OF SKIN MELANOMA


Cite item

Full Text

Abstract

Recent breakthroughs in the treatment of melanoma are associated with the systemic therapy by drugs of new classes, however, the place of surgery remains to be the main in the management of both localized and widespread melanoma. In this literature review, there are systematized the modern concepts of local excision of the primary tumor, the value of biopsy of sentinel lymph node and possibilities of surgical treatment of distant metastases of melanoma.

About the authors

P. V Melnikov

Moscow Regional Oncological Dispansery

Email: drmelnikov84@gmail.com
канд. мед. наук, врач-онколог 2-го онкологического хирургического отделения; 143900, Московская область, г. Балашиха, ул. Карбышева, д. 6 Balashikha, 143900, Russian Federation

References

  1. Cady B. Basic principles in surgical oncology. Arch Surg. 1997; 132: 338-46.
  2. Rebecca V.W., Sondak V.K., Smalley K.SM. A brief history of melanoma: from mummies to mutations. Melanoma Res. 2012; 22(2): 114-22.
  3. Weintraub A. Eight Milestones of 2015. In: The War on Cancer. Forbs.; 2016. http://www.forbes.com/sites/arleneweintraub/2016/01/01/8-milestones-of- 2015-in-the-war-on-cancer/#78aa4dd053bc
  4. McKinnon J.G., Starritt E.C., Scolyer R.A., McCarthy W.H., Thompson J.F. Histopathologic excision margin affects local recurrence rate: analysis of 2681 patients with melanomas ≤2 mm thick. Ann. Surg. 2005; 241(2): 326-33.
  5. Dong X.D., Tyler D., Johnson J.L., DeMatos P., Seigler H.F. Analysis of prognosis and disease progression after local recurrence of melanoma. Cancer. 2000; 88: 1063-71.
  6. Borgstein P.J., Meijer S., van Diest P.J. Are locoregional cutaneous metastases in melanoma predictable? Ann. Surg. Oncol. 1999; 6: 315-21.
  7. Karakousis C.P., Balch C.M., Urist M.M., Ross M.M., Smith T.J., Bartolucci A.A. Local recurrence in malignant melanoma: long-term results of the multiinstitutional randomized surgical trial. Ann. Surg. Oncol. 1996; 3: 446-52.
  8. McKinnon J.G., Starritt E.C., Scolyer R.A., McCarthy W.H., Thompson J.F. Histopathologic excision margin affects local recurrence rate: analysis of 2681 patients with melanomas ≤2 mm thick. Ann. Surg. 2005; 241(2): 326-33.
  9. Khayat D., Rixe O., Martin G., Soubrane C., Banzet M., Bazex J.A. et al. Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1-mm thick). Cancer. 2003; 97(8): 1941-6.
  10. Cohn-Cedermark G., Rutqvist L.E., Andersson R., Breivald M., Ingvar C., Johansson H. et al. Long term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8-2.0 mm. Cancer. 2000; 89(7): 1495-501.
  11. Cascinelli N. Margin of resection in the management of primary melanoma. Semin. Surg. Oncol. 1998; 14(4): 272-5.
  12. Balch C.M., Soong S.J., Smith T., Ross M.I., Urist M.M., Karakousis C.P. et al. Investigators From the Intergroup Melanoma Surgical Trial. Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann. Surg. Oncol. 2001; 8(2): 101-8.
  13. Hayes A.J., Maynard L., A’Hern R. et al. Long term follow up of survival in a randomised trial of wide or narrow excision margins in high risk primary melanoma. J. Clin. Oncol. 2015; 33 (Suppl.): Abstr. 9001.
  14. Gillgren P., Drzewiecki K.T., Niin M., Gullestad H.P., Hellborg H., Mansson-Brahme E. et al. 2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: a randomised, multicentre trial. Lancet. 2011; 378(9803): 1635-42.
  15. Cancer Council Australia and Australian Cancer Network SaNZGGW. Clinical Practice Guidelines for the Management of Melanoma in Australia and New Zealand, <http://www.cancer.org.au/content/pdf/HealthProfessionals/ ClinicalGuidelines/ClinicalPracticeGuidelines-Managementof Melanoma.pdf>; 2008 [accessed 26-10-15].
  16. NCCN. Clinical practice guidelines in oncology (NCCN Guidelines), www.nccn.org/professionals/physician_gls/f_guidelines.asp#melanoma>; [accessed 27-10-15].
  17. Marsden J.R., Newton-Bishop J.A., Burrows L. et al. Revised UK guidelines for the management of cutaneous melanoma 2010. J. Plast. Reconstr. Aesthet. Surg. 2010; 63(9): 1401-19.
  18. Garbe C., Hauschild A., Volkenandt M., Schadendorf D., Stolz W., Reinhold U. et al. Evidence and interdisciplinary consensus-based German guidelines: surgical treatment and radiotherapy of melanoma. Melanoma Res. 2008; 18(1): 61-7.
  19. Dummer R., Panizzon R., Bloch P.H., Burg G. Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma. Dermatology. 2005; 210(1): 39-44.
  20. Dutch Working Group on Melanoma. Skin melanoma. Utrecht, The Netherlands: Association of Comprehensive Cancer Centres (ACCC); 2012. http://www.oncoline.nl/uploaded/docs/melanoom/201208_vertaling%20Richtlijn%20melanoom%20def.pdf.
  21. Wheatley K., Wilson J.S., Gaunt P., Marsden J.R. Surgical excision margins in primary cutaneous melanoma: A meta-analysis and Bayesian probability evaluation. Cancer Treatю Rev. 2016; 42: 73-81.
  22. Grotz T.E., Markovic S.N, Erickson L.A. Mayo clinic consensus recommendations for the depth of excision in primary cutaneous melanoma. Mayo Clin. Proc. 2011; 86(6): 522-8.
  23. Cochran A.J., Morton D.L., Stern S., Lana A.M., Essner R., Wen D.R. Sentinel lymph nodes show profound downregulation of antigen-presenting cells of the paracortex: implications for tumor biology and treatment. Mod. Pathol. 2001; 14: 604-8.
  24. Morton D.L., Thompson J.F., Cochran A.J., Mozzillo N., Elashoff R., Essner R. et al. Sentinel-node biopsy or nodal observation in melanoma. N. Engl. J. Med. 2006; 355(13): 1307-17.
  25. Kyrgidis A., Tzellos T., Mocellin S. Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanoma. Cochrane Database Syst. Rev. 2015; 16(5): CD010307.
  26. Guggenheim M.M., Hug U., Jung F.J., Rousson V., Aust M.C., Calcagni M. et al. Morbidity and recurrence after completion lymph node dissection following sentinel lymph node biopsy in cutaneous malignant melanoma. Ann. Surg. 2008; 247(4): 687-93.
  27. Leiter U., Stadler R., Mauch C. Survival of SLNB-positive melanoma patients with and without complete lymph node dissection: A multicenter, randomized DECOG trial. J. Clin. Oncol. 2015; 33 (Suppl.): Abstr LBA9002.
  28. https://www.clinicaltrials.gov/ct2/show/NCT00297895
  29. Koyanagi K., Mori T., O’Day S.J., Martinez S.R., Wang H.J., Hoon D.S. et al. Association of circulating tumor cells with serum tumor-related methylated DNA in peripheral blood of melanoma patients. Cancer Res. 2006; 66(12): 6111-7.
  30. Fletcher W.S., Pommier R.F., Lum S., Wilmarth T.J. Surgical treatment of metastatic melanoma. Am. J. Surg. 1998; 175(5): 413-7.
  31. Wong J.H., Skinner K.A., Kim K.A., Foshag L.J., Morton D.L. The role of surgery in the treatment of nonregionally recurrent melanoma. Surgery. 1993;113: 389-94.
  32. Ollila D.W. Complete metastasectomy in patients with stage IV metastatic melanoma. Lancet Oncol. 2006; 7: 919-24.
  33. Ollila D.W., Hsueh E.C., Stern S.L., Morton D.L. Metastasectomy for recurrent stage IV melanoma. J. Surg. Oncol. 1999; 71(4): 209-13.
  34. Balch C.M., Soong S.J., Gershenwald J.E., Thompson J.F., Reintgen D.S., Cascinelli N. et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J. Clin. Oncol. 2001; 19(16): 3622-34.
  35. Barth A., Wanek L.A., Morton D.L. Prognostic factors in 1,521 melanoma patients with distant metastases. J. Am. Coll. Surg. 1995; 181(3): 193-201.
  36. Tafra L., Dale P.S., Wanek L.A., Ramming K.P., Morton D.L. et al. Resection and adjuvant immunotherapy for melanoma metastatic to the lung and thorax. J. Thorac. Cardiovasc. Surg. 1995; 110(1): 119-28.
  37. Caudle A.S., Ross M.I. Metastasectomy for stage IV melanoma: for whom and how much? Surg. Oncol. Clin. N. Am. 2011; 20(1): 133-44.
  38. Friedel G., Pastorino U., Buyse M., Ginsberg R.J., Girard P., Goldstraw P. et al. Resection of lung metastases: long-term results and prognostic analysis based on 5206 cases-the International Registry of Lung Metastases. Zbl. Chir. 1999; 124(2): 96-103.
  39. Ollila D.W., Stern S.L., Morton D.L. Tumor doubling time: a selection factor for pulmonary resection of metastatic melanoma. J. Surg. Oncol. 1998; 69(4): 206-11.
  40. Leo F., Cagini L., Rocmans P., Cappello M., Van Geel A.N., Maggi G. et al. Lung metastases from melanoma: when is surgical treatment warranted? Br. J. Cancer. 2000; 83(5): 569-72.
  41. Petersen R.P., Hanish S.I., Haney J.C., Miller C.C. 3rd, Burfeind W.R. Jr., Tyler D.S. et al. Improved survival with pulmonary metastasectomy: an analysis of 1720 patients with pulmonary metastatic melanoma. J. Thorac. Cardiovasc. Surg. 2007; 133(1): 104-10.
  42. Andrews S., Robinson L., Cantor A., DeConti R.C.Survival after surgical resection of isolated pulmonary metastases from malignant melanoma. Cancer Control. 2006; 13(3): 218-23.
  43. Neuman H.B., Patel A., Hanlon C., Wolchok J.D., Houghton A.N., Coit D.G. Stage-IV melanoma and pulmonary metastases: factors predictive of survival. Ann. Surg. Oncol. 2007; 14(10): 2847-53.
  44. Ollila D.W., Essner R., Wanek L.A., Morton D.L. Surgical resection for melanoma metastatic to the gastrointestinal tract. Arch. Surg. 1996; 131(9): 975-9.
  45. Amersi F.F., Terando A.M., Goto Y., Scolyer R.A., Thompson J.F., Tran A.N. et al. Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine. Clin. Cancer Res. 2008; 14(3): 638-45.
  46. Gutman H., Hess K.R., Kokotsakis J.A., Ross M.I., Guinee V.F., Balch C.M. Surgery for abdominal metastases of cutaneous melanoma. World J. Surg. 2001; 25(6): 750-8.
  47. Achkasov E.E., Pugaev A.V., Mel’nikov P.V., Alekperov S.F., Aleksandrov L.V, Posudnevskiy V.I. et al. Invaginational intestinal obstruction caused by metastatic melanoma. Khirurgiya. Zhurnal im N.I. Pirogova. 2013; (1): 83-7. (in Russian) / Ачкасов Е.Е., Пугаев А.В., Мельников П.В., Алекперов С.Ф., Александров Л.В, Посудневский В.И. и др. Инвагинационная тонкокишечная непроходимость, обусловленная метастазами меланомы в тонкую кишку. Хирургия. Журнал им Н.И. Пирогова. 2013; (1): 83-7.
  48. Rose D.M., Essner R., Hughes T.M., Tang P.C., Bilchik A., Wanek L.A. Surgical resection for metastatic melanoma to the liver: the John Wayne Cancer Institute and Sydney Melanoma Unit experience. Arch. Surg. 2001; 136(8): 950-5.
  49. Wood T.F., DiFronzo L.A., Rose D.M., Haigh P.I., Stern S.L., Wanek L. et al. Does complete resection of melanoma metastatic to solid intra-abdominal organs improve survival? Ann. Surg. Oncol. 2001; 8(8); 658-62.

Copyright (c) 2017 Eco-Vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies